Paradigm shift in transfusion practices during early COVID-19 pandemic: A single center retrospective study

Table 3 Demographic and clinical characteristics, n (%)

Variable	COVID era (n = 108)	Pre COVID era (n = 100)	P value
Demographics
Mean age, years	68	70	0.295
Sex
Male	51 (47.2)	49 (49)	0.798
Female	57 (52.8)	51 (51)	0.798
Race1
Caucasian	86 (79.6)	84 (84)	0.758
Hispanics	1 (0.9)	1 (1)	0.758
African American	8 (7.4)	3 (3)	0.758
Asian	2 (1.9)	2 (2)	0.758
Others	11 (10.2)	10 (10)	0.758
Clinical characteristics
Preexisting CVD	15 (13.9)	29 (29)	0.008
Prior GIB	11 (10.2)	8 (8)	0.585
Active antiplatelet/anticoagulant use	20 (18.5)	46 (46)	0.001
Inpatient VTE prophylaxis2	15 (13.9)	29 (29)	0.001
RBC transfusions in ICU	42 (38.9)	22 (22)	0.008

¹Race was determined by the participants.

²Unfractionated or low molecular weight heparin.

CVD: Cardiovascular disease; ICU: Intensive care unit; VTE: Venous thromboembolism; GIB: Gastrointestinal bleeding; COVID: Coronavirus disease.